# US 2003/0224440 A1 · Human VNO cDNA libraries

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0224440 A1
- Document ID: US20030224440A1
- Status: Published application
- Kind: A1
- Application number: 10/461,803
- Filed: 2003-06-12
- Published: 2003-12-04
- Earliest claimed: 2000-02-17
- Assignees: Pherin Pharmaceuticals, Inc.
- Inventors: Ronald C. Herman; David L. Berliner
- Web page: https://patentgrep.com/patent/US20030224440A1

## CPC

- C12N 15/1034: {Isolating an individual clone by screening libraries}
- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This invention relates to DNA libraries, in particular a human VNO cDNA library is described. Pheromone receptor cDNA once isolated is transfected into competent cells. The transfected cell lines provide a scaleable source of homogeneous material to develop efficient, automated high throughput screening assays for new vomeropherins, and thereby reduce the ongoing need for human volunteers in the preclinical phases of drug discovery. Identification and characterization of the human VNO receptor(s) will facilitate the development and commercialization of vomeropherins with improved specificity, and enhanced therapeutic efficacy in the treatment of the target diseases.

## Claims

### Claim 1

A human VNO cDNA library constructed from female tissue ATCC # PTA-1213.

### Claim 2

A human cDNA library of female VNO tissue characterized by the presence of cDNAs coding for neuron-specific enolase, protein gene product 9.5 and synaptophysin, and the absence of cDNA coding for olfactory marker protein, wherein cDNA inserts range from about 300 base pairs to about 3000 base pairs in length.

### Claim 3

A human cDNA library of female VNO tissue characterized by the presence of cDNAs encoding Gα proteins Gi1, Gi2, Gi3 and Golf.

### Claim 4

A human cDNA library of female VNO tissue characterized by the presence of cDNAs encoding adenylyl cyclase types 2, 3 and 7.

### Claim 5

cDNA corresponding to PP32 comprising SEQ ID Nos. 1 and 2.

### Claim 6

cDNA corresponding to PP33 comprising SEQ ID No. 3.

### Claim 7

cDNA corresponding to PP35 comprising SEQ ID No. 4 and 5.

### Claim 8

cDNA corresponding to PP38 comprising SEQ ID No. 6.

### Claim 9

cDNA corresponding to PP40 comprising SEQ ID No. 16.

### Claim 10

cDNA corresponding to PP41 comprising SEQ ID No. 17.

### Claim 11

A method of identifying cDNA inserts encoding pheromone receptors comprising:
(a) generating a cDNA library which contains clones carrying cDNA inserts from human female VNO;
(b) hybridizing nucleic acid molecules of the clones from the cDNA libraries generated in step (a) with probes prepared from the group consisting of G-protein-coupled receptors, rodent VNO receptors and human pseudogene sequences;
(c) selecting clones which hybridized with the probes; and
(d) isolating clones which carry the hybridized inserts, thereby identifying the inserts encoding pheromone receptors.

### Claim 12 (depends on 11)

The method of claim 11, wherein the probes are cDNA probes.

### Claim 13 (depends on 11)

The method of claim 11, wherein the probes are cRNA probes.

### Claim 14 (depends on 11)

The method of claim 11, wherein the probes are genomic DNA probes.

### Claim 15 (depends on 11)

The method of claim 11, wherein the probes are PCR amplicons.

### Claim 16 (depends on 11, 12, 13, 14, 15)

The cDNA inserts identified by the method of claims 11, 12, 13, 14 or 15.

### Claim 17

A method for identifying DNA inserts encoding pheromone receptors comprising:
(a) generating DNA libraries which contain clones carrying inserts from a sample containing human female vomeronasal organ tissue;
(b) contacting clones from the DNA libraries generated in step (a) with a nucleic acid molecule selected from the group consisting of G protein-coupled receptors, rodent VNO receptors and human pseudogene sequences, in appropriate conditions permitting hybridization of the cloned DNA and the nucleic acid molecule;
(c) selecting clones which hybridized with the nucleic acid molecule; and
(d) isolating the clones which carry the hybridized inserts, thereby identifying the inserts encoding the pheromone receptors.

### Claim 18

A method to identify DNA inserts encoding pheromone receptors comprising:
(a) generating DNA libraries which contain clones with inserts from a sample which contains at least one human female vomeronasal organ;
(b) contacting the clones from the DNA libraries generated in step (a) with appropriate polymerase chain reaction primers capable of specifically binding to nucleic acid molecules encoding pheromone receptors in appropriate conditions permitting the amplification of the hybridized inserts by polymerase chain reaction;
(c) selecting the amplified inserts; and
(d) isolating the amplified inserts, thereby identifying the inserts encoding the pheromone receptors.

### Claim 19 (depends on 18)

A method of claim 18, wherein the sample contains only human female vomeronasal organ cells.

### Claim 20 (depends on 17)

A method of claim 17, wherein the libraries are cDNA libraries.

### Claim 21 (depends on 18)

A method of claim 18, wherein the libraries are cDNA libraries.

### Claim 22 (depends on 17)

A method of claim 17, wherein the libraries are genomic DNA libraries.

### Claim 23 (depends on 18)

A method of claim 18, wherein the libraries are genomic DNA libraries.

### Claim 24 (depends on 17, 18, 19, 20, 21, 22, 23)

DNA inserts identified by the method of claim 17, 18, 19, 20, 21, 22 or 23.

### Claim 25

A method to isolate DNA molecules encoding pheromone receptors comprising:
(a) contacting a biological sample known to contain nucleic acids with appropriate polymerase chain reaction primers capable of specifically binding to nucleic acid molecules encoding pheromone receptors in appropriate conditions permitting the amplification of the hybridized molecules by polymerase chain reaction; and
(b) isolating the amplified molecules, thereby identifying the DNA molecules encoding the pheromone receptors.

### Claim 26 (depends on 25)

A method of claim 25, wherein the nucleic acid contained in the sample is DNA.

### Claim 27 (depends on 26)

A method of claim 26, wherein the nucleic acid contained in the sample is genomic DNA.

### Claim 28 (depends on 25, 26, 27)

The nucleic acid molecules isolated by the method of claim 25, 26 or 27.

### Claim 29

A method to isolate DNA molecules encoding pheromone receptors comprising:
(a) contacting a biological sample known to contain nucleic acids with appropriate polymerase chain reaction primers capable of specifically binding to nucleic acid molecules encoding pheromone receptors in appropriate conditions permitting the amplification of the hybridized molecules by Reverse Transcriptase (RT)-polymerase chain reaction; and
(b) isolating the amplified molecules, thereby identifying the DNA molecules encoding the pheromone receptors.

### Claim 30 (depends on 29)

A method of claim 29, wherein the nucleic acid contained in the sample is RNA.
